NCT04097236

Brief Summary

Pulmonary aspiration of gastric contents is a complication causing significant morbidity and mortality related to anesthesia. Ultrasound examination of the gastric antrum allows the detection of preoperative gastric contents contributing to the preoperative assessment of pulmonary aspiration risk. In particular, this examination is based on the qualitative analysis of gastric contents performed in the supine and in the right lateral decubitus, using a qualitative score which makes it possible to discriminate a low liquid content of a large liquid volume. This score has been described in patients and volunteers installed on a bed without elevation of the upper section of the bed. However, in several studies, this qualitative score has been achieved in the 45° semirecumbent position, which may have affected the diagnostic performance of the examination thus performed, as suggested by the results of a study recently conducted by the investigating team. This study therefore aims to compare the diagnostic performance of the qualitative analysis of the gastric antrum performed in the supine and the right lateral decubitus for the diagnosis of gastric volumes higher than 50 ml and 100 ml, according to the bed angle: 45 ° elevation or no elevation of the upper section of the bed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 15, 2019

Completed
4 months until next milestone

First Posted

Study publicly available on registry

September 20, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

November 27, 2019

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 6, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 6, 2021

Completed
Last Updated

September 3, 2025

Status Verified

August 1, 2025

Enrollment Period

1.8 years

First QC Date

May 15, 2019

Last Update Submit

August 26, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Calculation of the sensitivity

    Diagnostic performance of the qualitative examination of the gastric antrum in the 45° semirecumbent position.

    3 minutes

Secondary Outcomes (16)

  • Calculation of the specificity

    3 minutes

  • Calculation of the positive predictive value,

    3 minutes

  • Calculation of the negative predictive value

    3 minutes

  • Calculation of the positive and negative likelihood ratio.

    3 minutes

  • Diagnostic performance of the qualitative examination of the gastric antrum for the detection of gastric fluid volume ≥ 0.8 milliliters/kilogram (ml/kg) in the full supine and right lateral decubitus position and in the 45° semirecumbent position

    3 minutes

  • +11 more secondary outcomes

Study Arms (2)

45° semirecumbent position

ACTIVE COMPARATOR
Other: Qualitative and quantitative assessment of gastric content volume with bed elevation

No elevation of the upper section of the bed

ACTIVE COMPARATOR
Other: Qualitative and quantitative assessment of gastric content volume without bed elevation

Interventions

Ultrasound examination of the gastric antrum are performed 3 minutes after the ingestion of a volume of water (either 0, 50, 100, 150, or 200 milliliters (ml), determined by randomization). The procedure is repeated three times (three different volumes, the same volumes for each session with randomized order for each session).

45° semirecumbent position

Ultrasound examination of the gastric antrum are performed 3 minutes after the ingestion of a volume of water (either 0, 50, 100, 150, or 200 milliliters (ml), determined by randomization). The procedure is repeated three times (three different volumes, the same volumes for each session with randomized order for each session).

No elevation of the upper section of the bed

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults 18 years old or older
  • Last consumption of solids at least 6 hours before the start of the study, last consumption of clear fluids at least 2 hours before the start of the study
  • Informed consent must have been signed.
  • No significant medical history (American Society of Anesthesiologists (ASA) class 1)

You may not qualify if:

  • Adult unable to give informed consent
  • Previous gastrointestinal surgery
  • Medication affecting gastric motility
  • Digestive diseases, gastroparesis, diabetes mellitus with insulin
  • Pregnancy or breastfeeding
  • Obesity (Body Mass Index (BMI) ≥ 30 kilograms/meter² (kg/m²))

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospices Civils de Lyon

Bron, 69500, France

Location

Related Publications (1)

  • Bouvet L, Cordoval J, Barnoud S, Berlier J, Desgranges FP, Chassard D. Diagnostic performance of qualitative ultrasound assessment for the interpretation of point-of-care gastric ultrasound to detect high gastric fluid volume: A prospective randomized crossover study. J Clin Anesth. 2022 Oct;81:110919. doi: 10.1016/j.jclinane.2022.110919. Epub 2022 Jul 2.

    PMID: 35792453BACKGROUND

MeSH Terms

Conditions

Respiratory Aspiration of Gastric Contents

Condition Hierarchy (Ancestors)

Laryngopharyngeal RefluxGastroesophageal RefluxEsophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesRespiratory AspirationRespiration DisordersRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Sophie Barnoud, Dr

    Hospices Civils de Lyon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 15, 2019

First Posted

September 20, 2019

Study Start

November 27, 2019

Primary Completion

September 6, 2021

Study Completion

September 6, 2021

Last Updated

September 3, 2025

Record last verified: 2025-08

Locations